Hubert Lulka
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
Papers in
- Oncology 9
- Pancreatic and Hepatic Oncology Research 9
-
- Epigenetics and DNA Methylation 2
- RNA Interference and Gene Delivery 2
- Renal and related cancers 2
- Co-authors
- Louis Buscail (15 shared papers)Pierre Cordelier (15 shared papers)Flavie Sicard (3 shared papers)Marion Gayral (2 shared papers)Naı̈ma Hanoun (9 shared papers)Janick Sèlves (6 shared papers)Marlène Dufresne (7 shared papers)Luc Pénicaud (2 shared papers)
- Journals
- Molecular Therapy (3 papers)PLoS ONE (2 papers)Human Gene Therapy (2 papers)Cancer Gene Therapy (2 papers)Pancreatology (1 paper)
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
Hubert Lulka
21 papers receiving 858 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 241
- Oncology 368
- Genetics 131
- Biotechnology 60
- Molecular Biology 381
Countries citing papers authored by Hubert Lulka
This map shows the geographic impact of Hubert Lulka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hubert Lulka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hubert Lulka more than expected).
Fields of papers citing papers by Hubert Lulka
This network shows the impact of papers produced by Hubert Lulka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hubert Lulka. The network helps show where Hubert Lulka may publish in the future.
Co-authors
The 25 scholars most cited alongside Hubert Lulka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 187 | |
| 2 | 2009 | 185 | |
| 3 | 2011 | 95 | |
| 4 | 2014 | 85 | |
| 5 | 2006 | 65 | |
| 6 | 2015 | 36 | |
| 7 | 2006 | 33 | |
| 8 | 2013 | 30 | |
| 9 | 2014 | 25 | |
| 10 | 2020 | 25 | |
| 11 | 2009 | 25 | |
| 12 | 2013 | 22 | |
| 13 | 2006 | 17 | |
| 14 | 2006 | 14 | |
| 15 | 2005 | 12 | |
| 16 | 2022 | 6 | |
| 17 | 2021 | 5 | |
| 18 | 2023 | 4 | |
| 19 | 2024 | 3 | |
| 20 | 2024 | 2 |
About Hubert Lulka
Hubert Lulka is a scholar working on Oncology, Molecular Biology, Biotechnology, Genetics and Epidemiology, having authored 21 papers that have together received 877 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (9 papers), Cancer Research and Treatments (8 papers), Virus-based gene therapy research (7 papers), Neuroendocrine Tumor Research Advances (4 papers), Epigenetics and DNA Methylation (2 papers), Pancreatitis Pathology and Treatment (2 papers), RNA Interference and Gene Delivery (2 papers) and Renal and related cancers (2 papers). The work is most often cited by research in Cancer Research (241 citations), Oncology (368 citations), Genetics (131 citations), Biotechnology (60 citations) and Molecular Biology (381 citations). Hubert Lulka has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Louis Buscail, Pierre Cordelier, Flavie Sicard, Marion Gayral, Naı̈ma Hanoun, Janick Sèlves, Marlène Dufresne, Luc Pénicaud, Louis Casteilla and Jérôme Torrisani. Their work appears in journals such as Molecular Therapy, PLoS ONE, Human Gene Therapy, Cancer Gene Therapy and Pancreatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.